STATEMENT BY JOHN JENKINS, M.D. DIRECTOR, DIVISION OF PULMONARY DRUG PRODUCTS CENTER FOR DRUG EVALUATION AND RESEARCH FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES BEFORE THE SUBCOMMITTEE ON HEALTH AND THE ENVIRONMENT COMMITTEE ON COMMERCE U.S. HOUSE OF REPRESENTATIVES MAY 6, 1998
I. INTRODUCTION
ATTACHMENT A
List of Speakers
Open Public Meeting
Pulmonary and Allergy Drugs Advisory Committee
April 11, 1997
Speaker | Representative of | ||
---|---|---|---|
Nancy Sander | Allergy and Asthma Network/Mothers of Asthmatic, Inc. (AAN/MA) | ||
Michael Sauter | Strategic Insights, Inc. | ||
Ian Penn | Friends of the Earth | ||
Benjamin DeAngelo | Natural Resources Defense Council | ||
Malcolm Ko | Atmospheric and Environmental Research, Inc. | ||
John Craighead | University of Vermont School of Medicine | ||
Nancy Ostrum | Allergy and Asthma Medical Group and Research Center | ||
Janet Remetta | Chairperson, International Pharmaceutical Aerosol Consortium | ||
J. Douglas Wilson | Senior Vice President, Medical and Drug Regulatory Affairs, Boehringer Ingelheim Pharmaceutical, Inc. | ||
Kathleen Rickard | Director, Respiratory, US Medical Affairs, Glaxo Wellcome, Inc. | ||
Dean Handley | Director, Scientific Affairs, Sepracor, Inc. | ||
Mary Worstell | Executive Director, The Asthma and Allergy Foundation of America | ||
Alfred Munzer | Past President, American Lung Association | ||
John W. Georgitis | Chair, American College of Chest Physicians | ||
Daniel Ein | President Elect, Joint Council of Allergy,Asthma, and Immunology | ||
Charles Rice | National Association of Pharmaceutical Manufacturers | ||
Gene Colice | Associate Director, Clinical Research, 3M Pharmaceuticals | ||
Mark DuVal | Division Counsel, 3M Pharmaceuticals |